Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001129928-25-000093
Filing Date
2025-11-20
Accepted
2025-11-20 16:06:56
Documents
2
Period of Report
2025-11-20

Document Format Files

Seq Description Document Type Size
1 6-K form6kspecialmeetingupdate.htm 6-K 17848
2 EX-99.1 specialmtgupdate.htm EX-99.1 10749
  Complete submission text file 0001129928-25-000093.txt   29650
Mailing Address 804, 322 - 11 AVENUE SW CALGARY Alberta, Canada
Business Address 804, 322 - 11 AVENUE SW CALGARY Alberta, Canada 4036707377
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38512 | Film No.: 251503105
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)